BrownE.A.Erythropoietin dose: determined by the genes?Perit Dial Int2006; 26: 38–40.
2.
MrugM., StopkaT., JulianB.A., PrchalJ.F., PrchalJ.T.Angiotensin II stimulates proliferation of normal early erythroid progenitors.J Clin Invest1997; 100: 2310–14.
3.
ColeJ., ErtoyD., LinH., SutliffR.L., EzanE., GuyeneT.T.Lack of angiotensin II-facilitated erythropoiesis causes anemia in angiotensin-converting enzyme-deficient mice.J Clin Invest2000; 106: 1391–8.
4.
MacdougallI.C.The role of ACE inhibitors and angiotensin II receptor blockers in the response to epoetin.Nephrol Dial Transplant1999; 14: 1836–41.
5.
GrzegorzewskaA.E., LeanderM.Lymphocyte subset counts in CAPD patients in relation to administration of recombinant human erythropoietin and angiotensin-converting enzyme inhibitors.Perit Dial Int2002; 22: 625–8.
6.
GrzegorzewskaA.E., LeanderM.Lymphocyte subset counts in continuous ambulatory peritoneal dialysis patients in relation to administration of recombinant human erythropoietin and angiotensin-converting enzyme inhibitors.Adv Perit Dial2002; 18: 6–11.
7.
NavarroJ.F., MaciaM.L., Mora-FernándezC., GallegoE., ChahinJ., MéndezM.L.Effects of angiotensin-converting enzyme inhibitors on anemia and erythropoietin requirements in peritoneal dialysis patients.Adv Perit Dial1997; 13: 257–9.
